Free Trial
NASDAQ:OM

Outset Medical (OM) Stock Price, News & Analysis

Outset Medical logo
$0.84 +0.08 (+10.56%)
(As of 11/22/2024 ET)

About Outset Medical Stock (NASDAQ:OM)

Key Stats

Today's Range
$0.74
$0.90
50-Day Range
$0.52
$0.90
52-Week Range
$0.44
$6.37
Volume
551,986 shs
Average Volume
1.01 million shs
Market Capitalization
$44.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.70
Consensus Rating
Moderate Buy

Company Overview

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Outset Medical Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
48th Percentile Overall Score

OM MarketRank™: 

Outset Medical scored higher than 48% of companies evaluated by MarketBeat, and ranked 606th out of 953 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Outset Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Outset Medical has received no research coverage in the past 90 days.

  • Read more about Outset Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for Outset Medical are expected to grow in the coming year, from ($2.46) to ($1.93) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Outset Medical is -0.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Outset Medical is -0.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Outset Medical has a P/B Ratio of 0.92. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Outset Medical's valuation and earnings.
  • Percentage of Shares Shorted

    6.38% of the outstanding shares of Outset Medical have been sold short.
  • Short Interest Ratio / Days to Cover

    Outset Medical has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Outset Medical has recently decreased by 3.46%, indicating that investor sentiment is improving.
  • Dividend Yield

    Outset Medical does not currently pay a dividend.

  • Dividend Growth

    Outset Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.38% of the outstanding shares of Outset Medical have been sold short.
  • Short Interest Ratio / Days to Cover

    Outset Medical has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Outset Medical has recently decreased by 3.46%, indicating that investor sentiment is improving.
  • News Sentiment

    Outset Medical has a news sentiment score of -0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.49 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Outset Medical this week, compared to 5 articles on an average week.
  • Search Interest

    16 people have searched for OM on MarketBeat in the last 30 days. This is an increase of 433% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added Outset Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Outset Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $11,555.00 in company stock.

  • Percentage Held by Insiders

    Only 3.50% of the stock of Outset Medical is held by insiders.

  • Read more about Outset Medical's insider trading history.
Receive OM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Outset Medical and its competitors with MarketBeat's FREE daily newsletter.

OM Stock News Headlines

JD Vance Predicts: Wall Street vs. Trump & Your Money
Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.
Outset Medical (OM) Gets a Buy from Stifel Nicolaus
See More Headlines

OM Stock Analysis - Frequently Asked Questions

Outset Medical's stock was trading at $5.41 at the start of the year. Since then, OM shares have decreased by 84.5% and is now trading at $0.8376.
View the best growth stocks for 2024 here
.

Outset Medical, Inc. (NASDAQ:OM) announced its earnings results on Thursday, October, 12th. The company reported ($0.71) EPS for the quarter, beating analysts' consensus estimates of ($0.74) by $0.03. Outset Medical had a negative net margin of 122.84% and a negative trailing twelve-month return on equity of 164.92%.

Outset Medical (OM) raised $175 million in an IPO on Tuesday, September 15th 2020. The company issued 7,600,000 shares at a price of $22.00-$24.00 per share. BofA Securities, Morgan Stanley and Goldman Sachs served as the underwriters for the IPO and SVB Leerink and Stifel were co-managers.

Outset Medical's top institutional investors include FMR LLC (9.09%), GSA Capital Partners LLP (2.13%), Assenagon Asset Management S.A. (0.76%) and State Street Corp (0.37%). Insiders that own company stock include Leslie Trigg, Steven S Williamson, Nabeel Ahmed, Jean-Olivier Racine, Marc Nash, John L Brottem, Martin Vazquez, Stacey L Porter and D Keith Grossman.
View institutional ownership trends
.

Shares of OM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Outset Medical investors own include Pinterest (PINS), Shopify (SHOP), Trade Desk (TTD), Fiverr International (FVRR), Teladoc Health (TDOC), Lemonade (LMND) and Block (SQ).

Company Calendar

Last Earnings
10/12/2023
Today
11/23/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
2/19/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
Medical Equipment
Fax
N/A
Employees
520
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$4.70
High Stock Price Target
$6.00
Low Stock Price Target
$3.00
Potential Upside/Downside
+461.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.60
Research Coverage
5 Analysts

Profitability

Net Income
$-172,800,000.00
Net Margins
-122.84%
Pretax Margin
-122.32%

Debt

Sales & Book Value

Annual Sales
$130.38 million
Book Value
$0.91 per share

Miscellaneous

Free Float
50,703,000
Market Cap
$44.01 million
Optionable
Not Optionable
Beta
1.95
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:OM) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners